SCHEMBL4897482

SCHEMBL4897482

CCN(c1ccc(OCc2ccc(F)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
KEAP1 Q14145 6/20 0.51
NFE2L2 Q16236 6/20 0.51
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
MMP9 P14780 2/20 0.46
MMP2 P08253 1/20 0.46
NR4A2 P43354 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
PPARA Q07869 1/20 0.44
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904188 0.92 LMNA (0.53) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4895352 0.92 KMT2A (0.54) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4905993 0.91 LMNA (0.56) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4904032 0.90 KEAP1 (0.49) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4903420 0.90 LMNA (0.57) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4907030 0.90 LMNA (0.51) LMNAKMT2AHSD17B10MMP9MMP2
SCHEMBL4907113 0.90 LMNA (0.53) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4905308 0.90 MMP2 (0.49) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4897627 0.89 KEAP1 (0.48) LMNAKEAP1NFE2L2KMT2AHSD17B10
SCHEMBL4899425 0.89 LMNA (0.58) LMNAKMT2AHSD17B10TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885KEAP1 714/4885NFE2L2 451/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885KEAP1 810/4885NFE2L2 446/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885KEAP1 810/4885NFE2L2 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.